See more : Yamaha Motor Co., Ltd. (YMHAY) Income Statement Analysis – Financial Results
Complete financial analysis of Orion Biotech Opportunities Corp. (ORIA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Orion Biotech Opportunities Corp., a leading company in the Shell Companies industry within the Financial Services sector.
- Shaanxi Jinye Science Technology and Education Group Co.,Ltd (000812.SZ) Income Statement Analysis – Financial Results
- GTI Energy Ltd (GTR.AX) Income Statement Analysis – Financial Results
- Getinge AB (publ) (GETI-B.ST) Income Statement Analysis – Financial Results
- Tree Holdings Limited (8395.HK) Income Statement Analysis – Financial Results
- NetCents Technology Inc. (NC.CN) Income Statement Analysis – Financial Results
Orion Biotech Opportunities Corp. (ORIA)
About Orion Biotech Opportunities Corp.
Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.
Metric | 2022 | 2021 |
---|---|---|
Revenue | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 |
General & Administrative | 899.67K | 553.69K |
Selling & Marketing | 0.00 | 0.00 |
SG&A | 899.67K | 553.69K |
Other Expenses | 0.00 | 0.00 |
Operating Expenses | 899.67K | 553.69K |
Cost & Expenses | 899.67K | 553.69K |
Interest Income | 0.00 | 0.00 |
Interest Expense | 0.00 | 96.29K |
Depreciation & Amortization | -9.66M | -96.29K |
EBITDA | -10.56M | -724.50K |
EBITDA Ratio | 0.00% | 0.00% |
Operating Income | -899.67K | -628.21K |
Operating Income Ratio | 0.00% | 0.00% |
Total Other Income/Expenses | 9.66M | -96.29K |
Income Before Tax | 8.76M | -724.50K |
Income Before Tax Ratio | 0.00% | 0.00% |
Income Tax Expense | -9.66M | 96.29K |
Net Income | 18.41M | -820.79K |
Net Income Ratio | 0.00% | 0.00% |
EPS | 0.92 | -0.03 |
EPS Diluted | 0.92 | -0.03 |
Weighted Avg Shares Out | 20.00M | 18.79M |
Weighted Avg Shares Out (Dil) | 20.00M | 18.79M |
Source: https://incomestatements.info
Category: Stock Reports